Natural inhibitors of fibrinolysis

Natural inhibitors of fibrinolysis.

Future prospects for use of fibrinolysis inhibitors.

Natural peptides and proteins: potent tyrosinase inhibitors

Background and objectives: Tyrosinase is a copper containing oxidase which is crucial for controlling the production of melanin in creatures such as bacteria, fungi, plants and mammals. It is involved in the first two steps of melanin biosynthesis and leads to pigmentation and different types of cancer such as melanoma. Also, it is responsible for browning of fruits and vegetab...

Coagulation, fibrinolysis and fibrinolysis inhibitors in haemodialysis patients: contribution of arteriovenous fistula.

BACKGROUND End-stage renal disease (ESRD) patients, not uncommonly, might exhibit thrombotic complications, as well as they may present with a bleeding diathesis. Changes in vessel wall and/or blood flow in native arteriovenous fistula (AVF) might also augment these disarrangements, as vascular endothelium is predominantly involved in the regulation of haemostatic pathways. OBJECTIVE This stu...

Inhibitors of fibrinolysis: evidence of some instances of mutual potentiation.

Inhibitors of fibrinolysis may be divided into naturally circulating inhibitors and antifibrinolytic agents. Natural inhibitors are present in plasma and are components of blood cells, especially platelets. Several types of antifibrinolytic activity can be distinguished: antiplasmin activity, and anti-activator activity against streptokinase, urokinase, and tissue activator induced plasminogen ...